-
1
-
-
0023911753
-
Molecular genetics of lung cancer
-
Birrer MJ, Minna JD. Molecular genetics of lung cancer. Seminars Oncol 1988;15:226-35.
-
(1988)
Seminars Oncol
, vol.15
, pp. 226-235
-
-
Birrer, M.J.1
Minna, J.D.2
-
2
-
-
0026601682
-
A flow cytometric study of non-small cell lung cancer classified as T1N0
-
Schmidt RA, Rusch VW, Piantadosi S. A flow cytometric study of non-small cell lung cancer classified as T1N0. Cancer 1992;69:78-85.
-
(1992)
Cancer
, vol.69
, pp. 78-85
-
-
Schmidt, R.A.1
Rusch, V.W.2
Piantadosi, S.3
-
3
-
-
0029127622
-
Molecular and biological factors in the prognosis of non-small cell lung cancer
-
Kanters SDJM, Lammers JWJ, Voest EE. Molecular and biological factors in the prognosis of non-small cell lung cancer (Review). Eur Respir J 1995;8:1389-97.
-
(1995)
Eur Respir J
, vol.8
, pp. 1389-1397
-
-
Kanters, S.D.J.M.1
Lammers, J.W.J.2
Voest, E.E.3
-
4
-
-
0025851146
-
Relationship between K-ras oncogene activation and smoking in adenocarcinoma of the human lung
-
Slebos RJ, Hruban RH, Dalesio O, Mooi WJ, Offerhaus GJA, Rodenhuis S. Relationship between K-ras oncogene activation and smoking in adenocarcinoma of the human lung. J Natl Can Inst 1991;83:1024-7.
-
(1991)
J Natl Can Inst
, vol.83
, pp. 1024-1027
-
-
Slebos, R.J.1
Hruban, R.H.2
Dalesio, O.3
Mooi, W.J.4
Offerhaus, G.J.A.5
Rodenhuis, S.6
-
5
-
-
0025215880
-
Prognostic and therapeutic significance of the flow cytometric nuclear DNA content in non-small cell lung cancer
-
Isobe H, Miyamoto H, Shimizu T et al. Prognostic and therapeutic significance of the flow cytometric nuclear DNA content in non-small cell lung cancer. Cancer 1990;65:1391-5.
-
(1990)
Cancer
, vol.65
, pp. 1391-1395
-
-
Isobe, H.1
Miyamoto, H.2
Shimizu, T.3
-
6
-
-
0024421662
-
Differential expression of the c-erbB-2 gene in human small cell and non-small cell lung cancer
-
Schneider PM, Hung MCH, Chocca SM et al. Differential expression of the c-erbB-2 gene in human small cell and non-small cell lung cancer. Cancer Res 1989;49:4968-71.
-
(1989)
Cancer Res
, vol.49
, pp. 4968-4971
-
-
Schneider, P.M.1
Hung, M.C.H.2
Chocca, S.M.3
-
7
-
-
0025190758
-
Expression of neu gene-encoded protein (P185neu) in human non-small cell carcinomas of the lung
-
Weiner DB, Nordberg J, Robinson R, Nowell PC, Gazdar A, Greene MI. Expression of neu gene-encoded protein (P185neu) in human non-small cell carcinomas of the lung. Cancer Res 1990;50:421-5.
-
(1990)
Cancer Res
, vol.50
, pp. 421-425
-
-
Weiner, D.B.1
Nordberg, J.2
Robinson, R.3
Nowell, P.C.4
Gazdar, A.5
Greene, M.I.6
-
8
-
-
0026012263
-
Tumour markers and oncogenes in lung cancer
-
Mäkela TP, Mattson K, Alitalo K. Tumour markers and oncogenes in lung cancer. Eur J Cancer 1991;27:1323-7.
-
(1991)
Eur J Cancer
, vol.27
, pp. 1323-1327
-
-
Mäkela, T.P.1
Mattson, K.2
Alitalo, K.3
-
9
-
-
0025708183
-
P185neu expression in human lung adenocarcinomas predicts survival
-
Kern JA, Schwartz DA, Nordberg JE et al. p185neu expression in human lung adenocarcinomas predicts survival. Cancer Res 1990;50:5184-91.
-
(1990)
Cancer Res
, vol.50
, pp. 5184-5191
-
-
Kern, J.A.1
Schwartz, D.A.2
Nordberg, J.E.3
-
10
-
-
0027215146
-
Correlation of intrinsic chemoresistance of non-small-cell lung cancer cell lines with HER-2/neu gene expression but not with ras gene mutations
-
Tsai CM, Chang KT, Perng RP et al. Correlation of intrinsic chemoresistance of non-small-cell lung cancer cell lines with HER-2/neu gene expression but not with ras gene mutations. J Natl Cancer Inst 1993;85:897-901.
-
(1993)
J Natl Cancer Inst
, vol.85
, pp. 897-901
-
-
Tsai, C.M.1
Chang, K.T.2
Perng, R.P.3
-
11
-
-
0030044628
-
Enhancement of chemosensitivity by tryhostin AG825 in high-p185 (neu) expressing non-small cell lung cancer cells
-
Tsai CM, Levitzki A, Wu LH et al. Enhancement of chemosensitivity by tryhostin AG825 in high-p185 (neu) expressing non-small cell lung cancer cells. Cancer Res 1996;56:1068-74.
-
(1996)
Cancer Res
, vol.56
, pp. 1068-1074
-
-
Tsai, C.M.1
Levitzki, A.2
Wu, L.H.3
-
12
-
-
0030067015
-
Sensitization of HER-2/neu-overexpressing non-small cell lung cancer cells to chemotherapeutic drugs by tyrosine kinase inhibitor emodin
-
Zhang L, Hung MC. Sensitization of HER-2/neu-overexpressing non-small cell lung cancer cells to chemotherapeutic drugs by tyrosine kinase inhibitor emodin. Oncogene 1996;12:571-6.
-
(1996)
Oncogene
, vol.12
, pp. 571-576
-
-
Zhang, L.1
Hung, M.C.2
-
13
-
-
0030031576
-
Correlations between intrinsic chemoresistance and HER-2/neu gene expression, p53 gene mutations, and cell proliferation characteristics in non-small cell lung cancer cell lines
-
Tsai CM, Chang KT, Wu LH et al. Correlations between intrinsic chemoresistance and HER-2/neu gene expression, p53 gene mutations, and cell proliferation characteristics in non-small cell lung cancer cell lines. Cancer Res 1996;56:206-9.
-
(1996)
Cancer Res
, vol.56
, pp. 206-209
-
-
Tsai, C.M.1
Chang, K.T.2
Wu, L.H.3
-
14
-
-
0030964789
-
The erbB 2 oncogene and chemotherapy: A mini-review
-
Torre EA, Salimbeni V, Fulco RA. The erbB 2 oncogene and chemotherapy: a mini-review. J Chemother 1997;9:51-5.
-
(1997)
J Chemother
, vol.9
, pp. 51-55
-
-
Torre, E.A.1
Salimbeni, V.2
Fulco, R.A.3
-
15
-
-
0026543204
-
P53 gene mutation in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features
-
Mitsudomi T, Steinberg SM, Nau MM et al. P53 gene mutation in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene 1992;7:171-80.
-
(1992)
Oncogene
, vol.7
, pp. 171-180
-
-
Mitsudomi, T.1
Steinberg, S.M.2
Nau, M.M.3
-
16
-
-
0028034928
-
Genetic alterations in p53 and K-ras in lung cancer in relation to histopathology of the tumor and smoking history of the patient
-
Ridanpää M, Karjalainen A, Anttila S, Vainio H, Husgafvel-Pursiainen K. Genetic alterations in p53 and K-ras in lung cancer in relation to histopathology of the tumor and smoking history of the patient. Int J Oncol 1994;5:1109-17.
-
(1994)
Int J Oncol
, vol.5
, pp. 1109-1117
-
-
Ridanpää, M.1
Karjalainen, A.2
Anttila, S.3
Vainio, H.4
Husgafvel-Pursiainen, K.5
-
17
-
-
0026536320
-
Oncoprotein (c-myc, c-erbB1, c-erbB2, c-fos) and suppressor gene product (p53) expression in squamous cell carcinoma of the lung. Clinical and biological correlations
-
Volm M, Efferth T, Mattern J. Oncoprotein (c-myc, c-erbB1, c-erbB2, c-fos) and suppressor gene product (p53) expression in squamous cell carcinoma of the lung. Clinical and biological correlations. Anti Cancer Res 1992;12:11-20.
-
(1992)
Anti Cancer Res
, vol.12
, pp. 11-20
-
-
Volm, M.1
Efferth, T.2
Mattern, J.3
-
18
-
-
0005079456
-
Ras and p53 expression in non-small cell lung cancer patients: P53 over-expression correlates with poor prognosis
-
Papadakis E, Malliri A, Linardopoulos S, Karaiossifidi H, Field JK, Spandidos DA. Ras and p53 expression in non-small cell lung cancer patients: p53 over-expression correlates with poor prognosis. Int J Oncol 1992;1:403-13.
-
(1992)
Int J Oncol
, vol.1
, pp. 403-413
-
-
Papadakis, E.1
Malliri, A.2
Linardopoulos, S.3
Karaiossifidi, H.4
Field, J.K.5
Spandidos, D.A.6
-
19
-
-
0026557134
-
Clinocopathological significance of nuclear accumulation of tumor suppressor gene p53 product in primary lung cancer
-
Hiyoshi H, Matsuno Y, Kato H, Shimosato Y, Hirohashi S. Clinocopathological significance of nuclear accumulation of tumor suppressor gene p53 product in primary lung cancer. Jpn J Cancer Res 1992;83:101-6.
-
(1992)
Jpn J Cancer Res
, vol.83
, pp. 101-106
-
-
Hiyoshi, H.1
Matsuno, Y.2
Kato, H.3
Shimosato, Y.4
Hirohashi, S.5
-
20
-
-
0026756968
-
Reversible p53 expression in lung cancer
-
Pezzella F, Turkley H, Kuzu Y, Gatter KC, Mason DY, Harris DY. Reversible p53 expression in lung cancer. Lancet 1992;340:992.
-
(1992)
Lancet
, vol.340
, pp. 992
-
-
Pezzella, F.1
Turkley, H.2
Kuzu, Y.3
Gatter, K.C.4
Mason, D.Y.5
Harris, D.Y.6
-
21
-
-
0025838802
-
P53 immunostaining in benign breast disease
-
Heyderman E, Dagg B. P53 immunostaining in benign breast disease. Lancet 1991;338:1532.
-
(1991)
Lancet
, vol.338
, pp. 1532
-
-
Heyderman, E.1
Dagg, B.2
-
22
-
-
0026764822
-
Constitutive expression of P53 protein in enriched normal human marrow blast cell populations
-
Rivas CI, Wisniekski D, Strife A et al. Constitutive expression of P53 protein in enriched normal human marrow blast cell populations. Blood 1992;79:1982-6.
-
(1992)
Blood
, vol.79
, pp. 1982-1986
-
-
Rivas, C.I.1
Wisniekski, D.2
Strife, A.3
-
23
-
-
0026601682
-
A flow cytometric study of non-small cell lung cancer classified as T1N0
-
Schmidt RA, Rusch VW, Piantadosi S. A flow cytometric study of non-small cell lung cancer classified as T1N0. Cancer 1992;69:78-85.
-
(1992)
Cancer
, vol.69
, pp. 78-85
-
-
Schmidt, R.A.1
Rusch, V.W.2
Piantadosi, S.3
-
24
-
-
0022468532
-
Expression of epidermal growth factor receptor (EGF-R) in human lung tumors
-
Cerny T, Barnes DM, Hasleton P et al. Expression of epidermal growth factor receptor (EGF-R) in human lung tumors. Br J Cancer 1986;54:265-9.
-
(1986)
Br J Cancer
, vol.54
, pp. 265-269
-
-
Cerny, T.1
Barnes, D.M.2
Hasleton, P.3
-
25
-
-
0023261096
-
Epidermal growth factor receptors in non-small cell lung cancers
-
Veale D, Aschroft T, Marsh C, Gibson GJ, Harris AL. Epidermal growth factor receptors in non-small cell lung cancers. Br J Cancer 1987;55:513-6.
-
(1987)
Br J Cancer
, vol.55
, pp. 513-516
-
-
Veale, D.1
Aschroft, T.2
Marsh, C.3
Gibson, G.J.4
Harris, A.L.5
-
26
-
-
0024399929
-
Expression of epidermal growth factor receptor (EGF-R) in non-small cell lung cancer. Use of archival tissue correlation of EGF-R with histology, tumor size, node status and survival
-
Dazzi H, Hasleton PS, Thatcher N et al. Expression of epidermal growth factor receptor (EGF-R) in non-small cell lung cancer. Use of archival tissue correlation of EGF-R with histology, tumor size, node status and survival. Br J Cancer 1989;59:746-9.
-
(1989)
Br J Cancer
, vol.59
, pp. 746-749
-
-
Dazzi, H.1
Hasleton, P.S.2
Thatcher, N.3
-
27
-
-
0025768216
-
Epidermal Growth factor receptor in lung malignancies. Comparison between cancer and normal tissue
-
Dittadi R, Gion M, Brazzale A et al. Epidermal Growth factor receptor in lung malignancies. Comparison between cancer and normal tissue. Br J Cancer 1991;64:741-4.
-
(1991)
Br J Cancer
, vol.64
, pp. 741-744
-
-
Dittadi, R.1
Gion, M.2
Brazzale, A.3
-
28
-
-
0023279839
-
Epidermal growth factor receptor status as predictor of early recurrence and death from breast cancer
-
Sainsbury JR, Farndon JR, Needham GK, Malcolm AJ, Harris AL. Epidermal growth factor receptor status as predictor of early recurrence and death from breast cancer. Lancet 1987;I:1398-402.
-
(1987)
Lancet
, vol.1
, pp. 1398-1402
-
-
Sainsbury, J.R.1
Farndon, J.R.2
Needham, G.K.3
Malcolm, A.J.4
Harris, A.L.5
-
29
-
-
0345627988
-
P53 single strand conformation polymorphisms. Relationship of p53 molecular abnormalities with flow cytometry and growth factor receptor content in lung cancer
-
Löpez-Guerrero JA, Bolufer P, Marugan I, Barragán E, Vera FJ. P53 single strand conformation polymorphisms. Relationship of p53 molecular abnormalities with flow cytometry and growth factor receptor content in lung cancer. Clin Chim Acta 1998;269:63-76.
-
(1998)
Clin Chim Acta
, vol.269
, pp. 63-76
-
-
Löpez-Guerrero, J.A.1
Bolufer, P.2
Marugan, I.3
Barragán, E.4
Vera, F.J.5
-
31
-
-
0027378542
-
Lack of allelic deletion and point mutation as mechanisms of p53 activation in human malignant melanoma
-
Castresana JS, Rubio MP, Vazquez JJ et al. Lack of allelic deletion and point mutation as mechanisms of p53 activation in human malignant melanoma. Int J Cancer 1993;55:562-5.
-
(1993)
Int J Cancer
, vol.55
, pp. 562-565
-
-
Castresana, J.S.1
Rubio, M.P.2
Vazquez, J.J.3
-
32
-
-
0024756969
-
Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction
-
Orita M, Suzuki Y, Sekiya T, Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 1989;5:874-9.
-
(1989)
Genomics
, vol.5
, pp. 874-879
-
-
Orita, M.1
Suzuki, Y.2
Sekiya, T.3
Hayashi, K.4
-
33
-
-
0026769713
-
An immunohistochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53
-
Vojtesek B, Bartek J, Midgley CA. An immunohistochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53. J Immunol Methods 1992;151:237-44.
-
(1992)
J Immunol Methods
, vol.151
, pp. 237-244
-
-
Vojtesek, B.1
Bartek, J.2
Midgley, C.A.3
-
34
-
-
0019451604
-
Suppression of endogenous avidin-binding activity in tissues and its relevance to biotin-avidin detection systems
-
Wood GS, Warake R. Suppression of endogenous avidin-binding activity in tissues and its relevance to biotin-avidin detection systems. J Histochem Cytochem 1981;29:1196-204.
-
(1981)
J Histochem Cytochem
, vol.29
, pp. 1196-1204
-
-
Wood, G.S.1
Warake, R.2
-
35
-
-
0017184389
-
A rapid and sensitive method for quantification of microgram quantities of protein utilizing the principle of protein-dye binding
-
Bradford MM. A rapid and sensitive method for quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Annal Biochem 1976;72:248-54.
-
(1976)
Annal Biochem
, vol.72
, pp. 248-254
-
-
Bradford, M.M.1
-
36
-
-
17444442088
-
Immunocytochemical markers in stage I lung cancer: Relevance to prognosis
-
Pastorino U, Andreola S, Tagliabue E et al. Immunocytochemical markers in stage I lung cancer: relevance to prognosis. J Clin Oncol 1997;15:2858-65.
-
(1997)
J Clin Oncol
, vol.15
, pp. 2858-2865
-
-
Pastorino, U.1
Andreola, S.2
Tagliabue, E.3
|